Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model

References

• Abramov AY, Scorziello A, Duchen MR. (2007). Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci, 27, 1129–1138.
   PubMed Web of Science ®Google Scholar
• Akasofu S, Kosasa T, Kimura M, Kubota A. (2003). Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation. Eur J Pharmacol, 472, 57–63.
   PubMed Web of Science ®Google Scholar
• Augustinson KB. (1957). Assay methods for cholinesterase. In: Glick D, ed. Methods of biochemical analysis. New York: Interscience Publishers.
   Google Scholar
• Bajad S, Singla AK, Bedi KL. (2002). Liquid chromatographic method for determination of piperine in rat plasma: application to pharmacokinetics. J Chromatogr B Analyt Technol Biomed Life Sci, 776, 245–249.
   PubMed Web of Science ®Google Scholar
• Beckman KB, Ames BN. (1998). The free radical theory of aging matures. Physiol Rev, 78, 547–581.
   PubMed Web of Science ®Google Scholar
• Bhat BG, Chandrasekhara N. (1986). Studies on the metabolism of piperine: absorption, tissue distribution and excretion of urinary conjugates in rats. Toxicology, 40, 83–92.
   PubMed Web of Science ®Google Scholar
• Bhat BG, Chandrasekhara N. (1987). Metabolic disposition of piperine in the rat. Toxicology, 44, 99–106.
   PubMed Web of Science ®Google Scholar
• Blasi P, Schoubben A, Giovagnoli S, Rossi C, Ricci M. (2007). Solid lipid nanoparticles to improve brain drug delivery. Nanotechnologies for the Life Sciences. Wiley-VCH Verlag GmbH, Co. KGaA.
   Google Scholar
• Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. (2007). Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement, 3, 186–191.
   PubMed Web of Science ®Google Scholar
• Brown GC, Borutaite V. (2001). Nitric oxide, mitochondria, and cell death. IUBMB Life, 52, 189–195.
   PubMed Web of Science ®Google Scholar
• Bruce-Keller AJ, Begley JG, Fu W, Butterfield DA, Bredesen DE, Hutchins JB, Hensley K, Mattson MP. (1998). Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid β-peptide. J Neurochem, 70, 31–39.
   PubMed Web of Science ®Google Scholar
• Chang RC, Hudson PM, Wilson BC, Liu B, Abel H, Hong JS. (2000). High concentrations of extracellular potassium enhance bacterial endotoxin lipopolysaccharide-induced neurotoxicity in glia-neuron mixed cultures. Neuroscience, 97, 757–764.
   PubMed Web of Science ®Google Scholar
• Costantino L, Gandolfi F, Tosi G, Rivasi F, Vandelli MA, Forni F. (2005). Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. J Control Release, 108, 84–96.
   PubMed Web of Science ®Google Scholar
• Cui H, Kong Y, Zhang H. (2012). Oxidative stress, mitochondrial dysfunction, and aging. J Signal Transduction. DOI: 10.1155/2012/646354
   Google Scholar
• Cutler NR, Sramek JJ. (1993). Tacrine in Alzheimer’s disease. N Engl J Med, 328, 808; author reply 809–808; author reply 810.
   Google Scholar
• Davis K, Mohs R, Davis B, Levy M, Horvath T, Rosenberg G, editors. (1982). Cholinergic treatment in Alzheimer’s disease: Implications for future research. New York: Raven Press.
   Google Scholar
• Epstein WW, Netz DF, Seidel JL. (1993). Isolation of piperine from black pepper. J Chem Educ, 70, 598–602.
   Web of Science ®Google Scholar
• Fundarò A, Cavalli R, Bargoni A, Vighetto D, Zara GP, Gasco MR. (2000). Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol Res, 42, 337–343.
   PubMed Web of Science ®Google Scholar
• Gao K, Jiang X. (2006). Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int J Pharm, 310, 213–219.
   PubMed Web of Science ®Google Scholar
• Graf E, Mahoney JR, Bryant RG, Eaton JW. (1984). Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site. J Biol Chem, 259, 3620–3624.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Yaoi T, Koshiba H, Yoshida T, Maoka T, Fujiwara Y, Yamamoto Y, Mori K. (1996). Photochemical isomerization of piperine, a pungent constituent in pepper. Food Sci Tech Int, Tokyo, 2, 24–29.
   Google Scholar
• Hyrc K, Handran SD, Rothman SM, Goldberg MP. (1997). Ionized intracellular calcium concentration predicts excitotoxic neuronal death: observations with low-affinity fluorescent calcium indicators. J Neurosci, 17, 6669–6677.
   PubMed Web of Science ®Google Scholar
• Kakkar P, Das B, Viswanathan PN. (1984). A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys, 21, 130–132.
   PubMed Web of Science ®Google Scholar
• Kar S. (2002). Role of amyloid β peptides in the regulation of central cholinergic function and its relevance to Alzheimer’s disease pathology. Drug Dev Res, 56, 248–263.
   Web of Science ®Google Scholar
• Kar S, Slowikowski SP, Westaway D, Mount HT. (2004). Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease. J Psychiatry Neurosci, 29, 427–441.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Bhandari R, Bhandari S, Kakkar V. (2008). Potential of solid lipid nanoparticles in brain targeting. J Control Release, 127, 97–109.
   PubMed Web of Science ®Google Scholar
• Kim JH, Hahm DH, Lee HJ, Pyun KH, Shim I. (2009). Acori graminei rhizoma ameliorated ibotenic acid-induced amnesia in rats. Evid Based Complement Alternat Med, 6, 457–464.
   PubMed Web of Science ®Google Scholar
• Konishi T. (2009). Brain oxidative stress as basic target of antioxidant traditional oriental medicines. Neurochem Res, 34, 711–716.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2004). Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol, 4, 484–488.
   PubMed Web of Science ®Google Scholar
• Kuppusamy P, Zweier JL. (1989). Characterization of free radical generation by xanthine oxidase. Evidence for hydroxyl radical generation. J Biol Chem, 264, 9880–9884.
   PubMed Web of Science ®Google Scholar
• Lehninger AL. (1968). The neuronal membrane. Proc Natl Acad Sci USA, 60, 1069–1080.
   PubMed Web of Science ®Google Scholar
• Li F, Calingasan NY, Yu F, Mauck WM, Toidze M, Almeida CG, Takahashi RH, Carlson GA, Flint Beal M, Lin MT, Gouras GK. (2004). Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem, 89, 1308–1312.
   PubMed Web of Science ®Google Scholar
• Lipinski B. (2011). Hydroxyl radical and its scavengers in health and disease. Oxid Med Cell Longev, 2011, 809696.
   PubMed Web of Science ®Google Scholar
• Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD. (2003). Brain uptake of thiamine-coated nanoparticles. J Control Release, 93, 271–282.
   PubMed Web of Science ®Google Scholar
• Loveless VS, Surdock CP, Bhattacharjee H. (2010). Evaluation of zeta-potential and particle size of technetium 99mTc-sulfur colloid subsequent to the addition of lidocaine and sodium bicarbonate. J Nucl Med Technol, 38, 49–52.
   PubMedGoogle Scholar
• Mann DM. (1983). The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech Ageing Dev, 23, 73–94.
   PubMed Web of Science ®Google Scholar
• Markesbery LMA. (2007). Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol, 64, 954–956.
   PubMed Web of Science ®Google Scholar
• Mattson MP, Chan SL, Duan W. (2002). Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev, 82, 637–672.
   PubMed Web of Science ®Google Scholar
• Melov S, Adlard PA, Morten K, Johnson F, Golden TR, Hinerfeld D, Schilling B, Mavros C, Masters CL, Volitakis I, Li QX, Laughton K, Hubbard A, Cherny RA, Gibson B, Bush AI. (2007). Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE, 2, e536.
   PubMedGoogle Scholar
• Navarro A, Sánchez Del Pino MJ, Gómez C, Peralta JL, Boveris A. (2002). Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. Am J Physiol Regul Integr Comp Physiol, 282, R985–R992.
   PubMed Web of Science ®Google Scholar
• Palmer AM, Francis PT, Benton JS, Sims NR, Mann DM, Neary D, Snowden JS, Bowen DM. (1987). Presynaptic serotonergic dysfunction in patients with Alzheimer’s disease. J Neurochem, 48, 8–15.
   PubMed Web of Science ®Google Scholar
• Raghavendra M, Maiti R, Kumar S, Acharya S. (2009). Role of Ocimum sanctum in the experimental model of Alzheimer’s disease in rats. Int J Green Pharm, 3, 6–15.
   Google Scholar
• Roberson MR, Harrell LE. (1997). Cholinergic activity and amyloid precursor protein metabolism. Brain Res Brain Res Rev, 25, 50–69.
   PubMed Web of Science ®Google Scholar
• Schneider A, Moraru A, Krüger C, Laage R, Pitzer C. (2010). Use of Piperine and derivatives thereof for the therapy of neurological conditions. Heidelberg, DE: United States, SYNGIS Bioscience GmbH, Co. KG.
   Google Scholar
• Shen C, Chen Y, Liu H, Zhang K, Zhang T, Lin A, Jing N. (2008). Hydrogen peroxide promotes A β production through JNK-dependent activation of γ-secretase. J Biol Chem, 283, 17721–17730.
   PubMed Web of Science ®Google Scholar
• Sheng M, Sabatini BL, Südhof TC. (2012). Synapses and Alzheimer’s disease. Cold Spring Harb Perspect Biol, 4, a005777.
   Web of Science ®Google Scholar
• Skulachev VP. (1999). Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms. Mol Aspects Med, 20, 139–184.
   PubMedGoogle Scholar
• Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, Santoro G, Davit A, Danni O, Smith MA, Perry G, Tabaton M. (2005). β-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem, 92, 628–636.
   PubMed Web of Science ®Google Scholar
• Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu X, Smith MA, Perry G, Jo DG, Mattson MP, Tabaton M. (2008). Oxidative stress activates a positive feedback between the γ- and β-secretase cleavages of the β-amyloid precursor protein. J Neurochem, 104, 683–695.
   PubMed Web of Science ®Google Scholar
• Uttara B, Singh AV, Zamboni P, Mahajan RT. (2009). Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol, 7, 65–74.
   PubMed Web of Science ®Google Scholar
• Wagner S, Zensi A, Wien SL, Tschickardt SE, Maier W, Vogel T, Worek F, Pietrzik CU, Kreuter J, von Briesen H. (2012). Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model. PLoS ONE, 7, e32568.
   PubMed Web of Science ®Google Scholar
• Wang JX, Sun X, Zhang ZR. (2002). Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles. Eur J Pharm Biopharm, 54, 285–290.
   PubMed Web of Science ®Google Scholar
• Wang HY, Li W, Benedetti NJ, Lee DH. (2003). α 7 nicotinic acetylcholine receptors mediate β-amyloid peptide-induced tau protein phosphorylation. J Biol Chem, 278, 31547–31553.
   PubMed Web of Science ®Google Scholar
• Wegiel J, Frackowiak J, Mazur-Kolecka B, Schanen NC, Cook EH Jr, Sigman M, Brown WT, Kuchna I, Wegiel J, Nowicki K, Imaki H, Ma SY, Chauhan A, Chauhan V, Miller DL, Mehta PD, Flory M, Cohen IL, London E, Reisberg B, de Leon MJ, Wisniewski T. (2012). Abnormal intracellular accumulation and extracellular Aß deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders. PLoS ONE, 7, e35414.
   PubMedGoogle Scholar
• Weinstock M. (1995). The pharmacotherapy of Alzheimer’s disease based on the cholinergic hypothesis: an update. Neurodegeneration, 4, 349–356.
   PubMedGoogle Scholar
• Winyard PG, Moody CJ, Jacob C. (2005). Oxidative activation of antioxidant defence. Trends Biochem Sci, 30, 453–461.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev, 56, 1257–1272.
   PubMed Web of Science ®Google Scholar
• Wolfgang M, Karsten M. (2001). Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 47, 165–196.
   PubMed Web of Science ®Google Scholar
• Yusuf M, Khan RA, Khan M, Ahmed B. (2012). Plausible antioxidant biomechanics and anticonvulsant pharmacological activity of brain-targeted ß-carotene nanoparticles. Int J Nanomedicine, 7, 4311–4321.
   PubMed Web of Science ®Google Scholar
• Zhu X, Su B, Wang X, Smith MA, Perry G. (2007). Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci, 64, 2202–2210.
   PubMed Web of Science ®Google Scholar